Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
    3.
    发明授权
    Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor 失效
    醌基丙基哌啶衍生物,含有它们的中间体和组合物及其制备方法

    公开(公告)号:US06841562B2

    公开(公告)日:2005-01-11

    申请号:US10659095

    申请日:2003-09-10

    摘要: Quinolylpropylpiperidine derivatives of general formula (I) in which R1a is hydrogen, halogen, hydroxyl, amino, alkylamino, dialkylamino, hydroxyamino, alkoxyamino or alkylalkoxyamino and R1b is hydrogen, or R1a and R1b form an oxo, R2 is carboxyl, carboxymethyl or hydroxymethyl, R3 is alkyl either substituted with phenylthio optionally substituted with halogen, hydroxyl, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkoxycarbonyl, cyano or amino, or with cycloalkylthio (3 to 7 members) optionally substituted with halogen or trifluoromethyl, or with heteroarylthio (5 to 6 members and 1 to 4 heteroatoms chosen from N, O and S), optionally substituted with halogen, hydroxyl, alkyl, alkoxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkoxycarbonyl, cyano or amino or R3 is propargyl substituted with phenyl or heteroaryl as defined above, R4 is alkyl, alkenyl-CH2— or alkynyl-CH2—, cycloalkyl or cycloalkylalkyl, in their various isomeric forms, separate or as mixtures, and also their salts, their preparation process and intermediates and the compositions containing them. These novel derivatives are potent antibacterial agents.

    摘要翻译: 通式(I)的喹啉基丙基哌啶衍生物,其中R 1a是氢,卤素,羟基,氨基,烷基氨基,二烷基氨基,羟基氨基,烷氧基氨基或烷基烷氧基氨基,R 1b是氢,或者R 1a和R 1b形成氧代,R 2是羧基,羧甲基或羟甲基, 羟基,烷基,烷氧基,三氟甲基,三氟甲氧基,羧基,烷氧基羰基,氰基或氨基,或与任选被卤素或三氟甲基取代的环烷硫基(3至7个成员)或与杂芳硫基( 羟基,烷基,烷氧基,三氟甲基,三氟甲氧基,羧基,烷氧基羰基,氰基或氨基或R3是被苯基或杂芳基取代的炔丙基,被苯基或杂芳基取代 R4是烷基,烯基-CH 2 - 或炔基-CH 2 - ,环烷基或环烷基烷基,其各种异构体形式,分别或混合物,和 它们的盐,它们的制备方法和中间体以及含有它们的组合物。 这些新型衍生物是有效的抗菌剂。

    Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor
    8.
    发明授权
    Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor 失效
    醌基丙基哌啶衍生物,含有它们的中间体和组合物及其制备方法

    公开(公告)号:US07232834B2

    公开(公告)日:2007-06-19

    申请号:US10659164

    申请日:2003-09-10

    IPC分类号: A61K31/4545 C07D401/06

    摘要: Quinolylpropylpiperidine derivatives of general formula (I) in which R1 is hydrogen or fluorine, R2 is carboxyl, carboxymethyl or hydroxymethyl, R3 is alkyl substituted either with phenylthio optionally substituted with halogen, hydroxyl, alkyl, alkyloxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkyloxycarbonyl, cyano or amino, or with cycloalkylthio (3 to 7 members) optionally substituted with halogen or trifluoromethyl, or with heteroarylthio (5 to 6 members and 1 to 4 heteroatoms chosen from N, O and S), optionally substituted with halogen, hydroxyl, alkyl, alkyloxy, trifluoromethyl, trifluoromethoxy, carboxyl, alkyloxycarbonyl, cyano or amino or R3 is propargyl substituted by phenyl or heteroaryl as defined above and R4 is alkyl, alkenyl-CH2— or alkynyl-CH2—, cycloalkyl or cycloalkylalkyl, in their various isomeric forms, separate or as mixtures, and also their salts, their preparation process and intermediates and the compositions containing them. These novel derivatives are potent antibacterial agents

    摘要翻译: R 1是氢或氟的通式(I)的喹啉基丙基哌啶衍生物,R 2是羧基,羧甲基或羟甲基,R 3是 被任选被卤素,羟基,烷基,烷氧基,三氟甲基,三氟甲氧基,羧基,烷氧基羰基,氰基或氨基取代的苯硫基取代或被任选被卤素或三氟甲基取代的环烷硫基(3至7成员)或与杂芳硫基 6个成员和1至4个选自N,O和S的杂原子),任选被卤素,羟基,烷基,烷氧基,三氟甲基,三氟甲氧基,羧基,烷氧基羰基,氰基或氨基取代的杂原子,或者R 3是炔丙基 被如上定义的苯基或杂芳基取代,并且R 4是烷基,链烯基-CH 2 - 或炔基-CH 2 - ,环烷基或环烷基烷基 以其各种异构体形式,分别或作为混合物,以及它们的盐,其制备方法和含量 ermediates和含有它们的组合物。 这些新型衍生物是有效的抗菌剂

    Perhydroisoindole derivatives as antagonists of substance P
    10.
    发明授权
    Perhydroisoindole derivatives as antagonists of substance P 失效
    全氟异吲哚衍生物作为P物质的拮抗剂

    公开(公告)号:US5484804A

    公开(公告)日:1996-01-16

    申请号:US313121

    申请日:1994-10-11

    摘要: This invention relates to novel perhydroisoindole derivatives of general formula (I), ##STR1## wherein radicals R are phenyl radicals optionally 2- or 3-substituted by a halogen atom or a methyl radical; R.sub.1 is optionally substituted phenyl, cyclohexadienyl, naphthyl, indenyl or optionally substituted heterocyclyl; R.sub.2 is H, halogen, OH, alkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkyloxy, alkylthio, acyloxy, carboxy, optionally substituted alkyloxycarbonyl, benzyloxycarbonyl, amino or acylamino; R.sub.3 is optionally 2-substituted phenyl; R.sub.4 is OH or fluorine when R.sub.5 is H, or R.sub.4 and R.sub.5 are OH or R.sub.4 and R.sub.5 together form a bond; isomeric forms and mixtures thereof; optionally salts thereof where applicable; and preparation thereof. The novel derivatives are particularly useful as P substance antagonists.

    摘要翻译: PCT No。PTC / FR93 / 00352 Sec。 371日期:1994年10月11日 102(e)日期1994年10月11日PCT提交1993年4月8日PCT公布。 公开号WO93 / 21155 本发明涉及通式(I)的新型全氢异吲哚衍生物,其中基团R是任选被卤素原子或甲基取代的2-或3-取代的苯基; R1是任选取代的苯基,环己二烯基,萘基,茚基或任选取代的杂环基; R2是H,卤素,OH,烷基,氨基烷基,烷基氨基烷基,二烷基氨基烷基,烷氧基,烷硫基,酰氧基,羧基,任选取代的烷氧基羰基,苄氧羰基,氨基或酰氨基; R3是任选的2-取代的苯基; 当R 5为H或R 4和R 5为OH或R 4和R 5一起形成键时,R 4为OH或氟; 异构形式及其混合物; 任选的盐; 及其制备。 新型衍生物作为P物质拮抗剂是特别有用的。